期刊文献+

HDM2和p53蛋白的相互作用及其抑制剂的研究 被引量:5

Studies on the interaction of HDM2 and p53 and their inhibitors
下载PDF
导出
摘要 HDM 2和 p5 3蛋白之间存在一个自动调节的负反馈环。通过抑制二者的相互作用可治疗肿瘤。近年来 ,寻找抑制这种相互作用的药物已成为肿瘤治疗的研究热点。
出处 《国外医学(肿瘤学分册)》 2002年第4期255-258,共4页 Foreign Medical Sciences (Cancer Section)
基金 国家自然科学基金资助项目 (3 9870 862 )
  • 相关文献

参考文献14

  • 1Juven Gershon T, Oren M. Mdm2 : the ups and downs [J]. Mol Med, 1999, 5(2): 71-83.
  • 2Momand J, Jung D, Wilczynski S, et al. The MDM2 gene amplification database[J]. Nucleic Acids Res, 1998, 26(15): 3453-3459.
  • 3Garcia Echeverria C, Chene P, Blommers MJ, et al. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53[J]. J Med Chem, 2000, 43(17): 3205-3208.
  • 4Mayo LD, Turchi JJ, Berberich SJ. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53[J]. Cancer Res, 1997, 57(22): 5013-5016.
  • 5Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways[J]. Cell, 1998, 92(6): 725-734.
  • 6Lane DP, Hall PA. MDM2-arbiter of p53's destruction[J]. Trends Biochem Sci, 1997, 22(10): 372-374.
  • 7Bottger A, Bottger V, Garcia Echeverria C, et al. Molecular characterization of the hdm2-p53 interaction[J]. J Mol Biol, 1997, 269(5): 744-756.
  • 8Blaydes Jp, Gire V, Rowson JM, et al. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regu-lation by mdm-2[J]. Oncogene, 1997, 14(15): 1859-1868.
  • 9Wasylyk C, Salvi R, Argentini M, et al. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53[J]. Oncogene, 1999, 18(11): 1921-1934.
  • 10Chen L, Agrawal S, Zhou W, et al. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage[J]. Proc Natl Acad Sci USA, 1998, 95(1): 195-200.

同被引文献27

  • 1程玲,杨庆春,郑美蓉,车向新.MDM2在原发性肝细胞癌中的表达[J].中国组织化学与细胞化学杂志,2004,13(4):503-506. 被引量:5
  • 2Flores C,Sobrevia L.Tumorogenesis and MDM2 protein.Rev Med Chil,2000,128: 539.
  • 3Gougoulis V G,Zacharatos P,Mariatos G et al.Transcription factor E2F-1acts as a growth-promoting factor and is associated with adverse pronosis in non-small cell lung carcinomas.J Pathol,2002,198: 139.
  • 4Leite K R,Franco M F,Srougi M et al.Abnormal expression of MDM2 in prostate carcinoma.Mod Pathol,2001,14: 428.
  • 5Endo K,Ueda T,Ohta T et al.Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma.Liver,2000,20: 209.
  • 6Attradi L D.The role of p53 in tumor suppression: lessons from mouse models.Cell Mol Life,1999,55: 48.
  • 7Goussia A C,Ioachim E,Agnantis N J et al.Bcl-2 expression in colorectal tumours.Correlation with p53,MDM2,Rb proteins and proliferation indices.Histol Histopathol,2000,15: 667.
  • 8Dawson R,Muller L,Dehner A et al.The N-terminal domain of p53 is natively unfolded.J Mol Biol,2003,332: 1131.
  • 9Haines DS.The MDM2 proto-oncogene[J].Leuk Lymph,1997,26:227-238
  • 10Martinez JC,Mateo M,Sanchez-Beato M,et al.MDM2 Expression in lymphoid cells and reactive and neoplastic lymphoid tissue.Comparative study with p53 expression [J].J Pathol 1995,177(1):27-34

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部